United Therapeutics CEO Martine Rothblatt disposes of USD 3.29 million in common shares
UTHR•Post-transaction holdings
Direct common stock holdings ended at 40,513 shares.
Directly held stock options ended at 20,718.
Rothblatt exercises options and sells shares
United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares on July 10, 2026 at USD 135.42.
Rothblatt sold 9,500 shares the same day in multiple trades at weighted-average prices of about USD 540.37 to USD 553.47.
